In the news
Prime Therapeutics buying Magellan Health’s pharma business for $1.35 billion
May 5, 2022Minneapolis/St. Paul Business Journal
Related news
In the news
July 12, 2024
Study Shows 85% Of Patients Discontinue GLP-1s For Weight Loss After 2 Years
Forbes
In the news
July 11, 2024
Only 1 in 4 Still Taking Ozempic, Wegovy for Weight Loss Two Years Later
U.S. News & World Report